Japanese Encephalitis IgG ELISA

The JE IgG test for exposure to Japanese Encephalitis Virus (JEV) is an ELISA assay system for the detection of antibodies in human serum to JEV derived recombinant antigen (JERA) (1-4).

Regulatery Status: CE
Catalog No Size
Product Catalog No: EIA-4518 Pack Size: 96 Wells

Pack Size:
Pack Size:
Pack Size:
Pack Size:

Category:
Summary

Exposure to JEV causes a disease with a number of symptoms including encephalitis (5-8). The JE IgG assay employs a recombinant antigen called JERA, which can be used as a rapid serological marker for JEV infection. The JERA protein is a recombinant antigen, which consists of a stretch of peptides from different parts of the JEV antigens.

Test Principle

The JE IgG ELISA consists of one enzymatically amplified “two-step” sandwich-type immunoassay.

In this assay, JE IgG Weak Positive Control (Represents reactive or equivocally reactive serum), JE Negative Control (Represents non-reactive serum), and unknown serum samples are incubated in microtitration wells. The serum samples may be diluted with Sample Dilution Buffer for IgG. After incubation and washing, the wells are treated with an antibody specific for human IgG and labeled with the enzyme horseradish peroxidase (HRP). After a second incubation and washing step, the wells are incubated with the tetramethylbenzidine (TMB) substrate.

Note: Depending on the strength of antibody response, sera can be diluted in the “Sample Dilution Buffer for JE IgG” provided in the kit.

An acidic stopping solution is then added and the degree of enzymatic turnover of the substrate is determined by absorbance measurement at 450 nanometers. Above a certain threshold, the ratio of the absorbencies of the JERA and the control wells accurately determines whether antibodies to JEV are present.

Order Enquiry

    Order Enquiry Form

    References
    • Martin, D.A., Muth, D.A., Brown, T., Johnson, A.J., Karabatsos,R, Roehrig, J.T. 2000. Standardization of Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assays for Routine Diagnosis of Arboviral Infections. J. Clin. Microbiol. 38(5):1823-1826.
    • Cardosa MJ, Wang SM, Sum MS, Tio PH. Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol. 2002 May 5;2(1):9
    • Pandey B, Yamamoto A, Morita K, Kurosawa Y, Rai S, Adhikari S, Kandel P, Kurane I. Serodiagnosis of Japanese encephalitis among Nepalese patients by the particle agglutination assay Epidemiol Infect. 2003 Oct;131(2):881-5.
    • Thakare JP, Gore MM, Risbud AR, Banerjee K, Ghosh SN. Detection of virus specific IgG subclasses in Japanese encephalitis patients. Indian J Med Res. 1991 Sep;93:271-6.
    • Lowry PW, Truong DH, Hinh LD, Ladinsky JL, Karabatsos N, Cropp CB, Martin D, and Gubler DJ. Japanese encephalitis among hospitalized pediatric and adult patients with acute encephalitis syndrome in Hanoi, Vietnam 1995. Am. J. Trop. Med. Hyg, 1998;58(3):324-329.
    Enquiry